These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10798607)

  • 1. Phagocytic killing and antibody response during the first year after tetravalent meningococcal vaccine in complement-deficient and in normal individuals.
    Schlesinger M; Kayhty H; Levy R; Bibi C; Meydan N; Levy J
    J Clin Immunol; 2000 Jan; 20(1):46-53. PubMed ID: 10798607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency.
    Schlesinger M; Greenberg R; Levy J; Kayhty H; Levy R
    J Infect Dis; 1994 Aug; 170(2):449-53. PubMed ID: 8035035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
    Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
    Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera.
    Söderström C; Braconier JH; Käyhty H; Sjöholm AG; Thuresson B
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):220-4. PubMed ID: 2496990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis.
    Drogari-Apiranthitou M; Fijen CA; Thiel S; Platonov A; Jensen L; Dankert J; Kuijper EJ
    Immunopharmacology; 1997 Dec; 38(1-2):93-9. PubMed ID: 9476120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients.
    Platonov AE; Vershinina IV; Käyhty H; Fijen CA; Würzner R; Kuijper EJ
    Int Arch Allergy Immunol; 2003 Apr; 130(4):314-21. PubMed ID: 12740533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine.
    Platonov AE; Beloborodov VB; Pavlova LI; Vershinina IV; Käyhty H
    Clin Exp Immunol; 1995 Apr; 100(1):32-9. PubMed ID: 7697919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.
    Drogari-Apiranthitou M; Fijen CA; Van De Beek D; Hensen EF; Dankert J; Kuijper EJ
    Clin Exp Immunol; 2000 Feb; 119(2):311-6. PubMed ID: 10632668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of growth-inhibiting (bactericidal) antibodies in patients with meningococcal meningitis and in subjects immunized with meningococcal polysaccharide vaccine by a [3H]thymidine assay.
    Hassan-King M; Greenwood BM; Whittle HC
    J Clin Microbiol; 1985 Jul; 22(1):136-8. PubMed ID: 3926814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine.
    Aase A; Bjune G; Høiby EA; Rosenqvist E; Pedersen AK; Michaelsen TE
    Infect Immun; 1995 Sep; 63(9):3531-6. PubMed ID: 7642288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
    Brodszki N; Skattum L; Bai X; Findlow H; Borrow R; Jönsson G
    Vaccine; 2015 Apr; 33(15):1839-45. PubMed ID: 25707694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.
    van Ravenhorst MB; Marinovic AB; van der Klis FR; van Rooijen DM; van Maurik M; Stoof SP; Sanders EA; Berbers GA
    Vaccine; 2016 Dec; 34(50):6309-6315. PubMed ID: 27817957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.
    Selander B; Käyhty H; Wedege E; Holmström E; Truedsson L; Söderström C; Sjöholm AG
    J Clin Immunol; 2000 Mar; 20(2):138-49. PubMed ID: 10821465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
    Herva E; Leinonen M; Käyhty H; Mäkelä PH; Vetoniemi-Korhonen SL
    J Infect; 1983 Jan; 6(1):55-60. PubMed ID: 6411822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.
    Rennels M; King J; Ryall R; Papa T; Froeschle J
    Pediatr Infect Dis J; 2004 May; 23(5):429-35. PubMed ID: 15131466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against meningococcus in complement-deficient individuals.
    Morgan BP; Orren A
    Clin Exp Immunol; 1998 Dec; 114(3):327-9. PubMed ID: 9844038
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.
    Granoff DM; Gupta RK; Belshe RB; Anderson EL
    J Infect Dis; 1998 Sep; 178(3):870-4. PubMed ID: 9728562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.